(A) Agilent Technologies - Ratings and Ratios

Agilent Technologies, Inc. is a leader in providing application-focused solutions for the life sciences, diagnostics, and applied chemical markets globally. The company excels in analytical instruments, playing a crucial role in pharmaceuticals, biotechnology, and research. Its Life Sciences and Applied Markets segment offers advanced chromatography systems, mass spectrometry instruments, and software solutions that enhance laboratory efficiency and data integration. The Diagnostics and Genomics segment delivers cutting-edge tools for genomics and cell analysis, aiding in medical research and diagnostics. Agilent CrossLab provides comprehensive services, including instrument maintenance and software support, ensuring optimal lab operations. Incorporated in 1999, Agilent is headquartered in Santa Clara, California, and is recognized for its commitment to innovation and customer support.

Over the next three months, Agilent is expected to face a challenging environment. Technically, the stocks last price of $102.48 is below its SMA20 ($110.14) and SMA50 ($122.08), indicating a potential downtrend. The ATR of 4.33 signals higher volatility. Fundamentally, with a P/E of 23.50 and forward P/E of 18.42, the market may anticipate earnings growth. The Market Cap of $29.2 billion underscores its large-cap status. A P/S of 4.47 reflects moderate revenue valuation. While the RoE of 20.89% highlights strong profitability, investors should monitor these metrics closely for potential shifts in market sentiment.